Coronavirus information from UCLA and UCLA Health
MyoGene Bio

MyoGene Bio

MagnifyThe Next Generation Incubator MyoGene Bio is developing cutting edge therapeutics for muscle diseases, starting with a gene editing therapy for Duchenne muscular dystrophy. Market:Duchenne muscular dystrophy (DMD) is a severe, progressive muscle wasting...
Myst Therapeutics

Myst Therapeutics

MagnifyThe Next Generation Incubator Myst Therapeutics, Inc. is developing novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy solid tumor cancer cells. Market:Over 400,000 Americans die from cancer every year,...
Nammi Therapeutics

Nammi Therapeutics

MagnifyThe Next Generation Incubator Nammi Therapeutics, Inc. is a pre-clinical stage biotech company focused on optimizing cancer immunotherapy by using nanocarriers to deliver synergistic anti-tumor and immune activating agents to the tumor. Market:Nammi...
Pelage Pharmacueticals

Pelage Pharmacueticals

MagnifyThe Next Generation Incubator Pelage Pharmaceuticals, Inc. is a biotechnology company developing novel drugs to promote hair health. Market:Currently, 400 million people, both men and women, suffer from Alopecia worldwide. There are only two FDA-approved...
Qwixel Therapeutics

Qwixel Therapeutics

MagnifyThe Next Generation Incubator Qwixel Therapeutics addresses the need to develop therapeutics to treat multiple myeloma (MM), a B cell cancer disease that is not curable. Market:The anti-CD138 fused with Interferon (IFN) will both directly kill the malignant...